Cargando…
Targeting Telomerase Enhances Cytotoxicity of Salinomycin in Cancer Cells
[Image: see text] Salinomycin exhibits significant systemic adverse reactions such as tachycardia and myoglobinuria in mammals, which hinders its application as a drug for human cancers. Although many strategies aimed at increasing salinomycin’s toxicity to cancer cells have been identified to allow...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2022
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9435028/ https://www.ncbi.nlm.nih.gov/pubmed/36061682 http://dx.doi.org/10.1021/acsomega.2c04082 |